Phibro Animal Health Corporation (PAHC) Stock Score, Valuation & Financial Research
Phibro Animal Health Corporation is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.
Quick answer for PAHC
Phibro Animal Health Corporation currently has a Wall Street Score of 34/100. The stored market price is $36.23. Its financial score is 25/100. Its valuation score is 10/100. These figures are a research snapshot, not a buy or sell recommendation.
What Phibro Animal Health Corporation does
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating par
PAHC financial snapshot
- Wall Street Score:
- 34/100
- Current price:
- $36.23
- Market capitalization:
- $1.47B
- Revenue:
- $1.50B
- Net income:
- $95.2M
- Free cash flow:
- $41.8M
- Cash:
- $54.9M
- Total debt:
- $787.4M
- EPS:
- 1.19
- P/E ratio:
- 30.4x
- Financial score:
- 25/100
- Valuation score:
- 10/100
- Revenue score:
- 48/100
What stands out
- Reported year-over-year revenue growth is +0.2%.
- Free cash flow is $41.8M, showing positive cash generation.
- The balance sheet shows $54.9M of cash versus $787.4M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 10/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research PAHC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.